These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28361104)

  • 1. Discordance in selected designee for return of genomic findings in the event of participant death and estate executor.
    Goodman JL; Amendola LM; Horike-Pyne M; Trinidad SB; Fullerton SM; Burke W; Jarvik GP
    Mol Genet Genomic Med; 2017 Mar; 5(2):172-176. PubMed ID: 28361104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The return of results of deceased research participants.
    Tassé AM
    J Law Med Ethics; 2011; 39(4):621-30. PubMed ID: 22084848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank.
    Breitkopf CR; Petersen GM; Wolf SM; Chaffee KG; Robinson ME; Gordon DR; Lindor NM; Koenig BA
    J Law Med Ethics; 2015; 43(3):464-75. PubMed ID: 26479556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return of individual research results: What do participants prefer and expect?
    Sayeed S; Califf R; Green R; Wong C; Mahaffey K; Gambhir SS; Mega J; Patrick-Lake B; Frazier K; Pignone M; Hernandez A; Shah SH; Fan AC; Krüg S; Shaack T; Shore S; Spielman S; Eckstrand J; Wong CA;
    PLoS One; 2021; 16(7):e0254153. PubMed ID: 34324495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of individual results in epilepsy genomic research: A view from the field.
    Ottman R; Freyer C; Mefford HC; Poduri A; Lowenstein DH;
    Epilepsia; 2018 Sep; 59(9):1635-1642. PubMed ID: 30098010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical checklist for return of results from genomic research in the European context.
    Vears DF; Hallowell N; Bentzen HB; Ellul B; Nøst TH; Kerasidou A; Kerr SM; Th Mayrhofer M; Mežinska S; Ormondroyd E; Solberg B; Sand BW; Budin-Ljøsne I
    Eur J Hum Genet; 2023 Jun; 31(6):687-695. PubMed ID: 36949262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death.
    Amendola LM; Horike-Pyne M; Trinidad SB; Fullerton SM; Evans BJ; Burke W; Jarvik GP
    J Law Med Ethics; 2015; 43(3):476-85. PubMed ID: 26479557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The last will: Estate divisions as a testament of to whom altruism is directed.
    Elinder M; Engström P; Erixson O
    PLoS One; 2021; 16(7):e0254492. PubMed ID: 34320017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Act amending the Inheritance Code, 14 May 1987.
    Sweden
    Annu Rev Popul Law; 1989; 16():75, 460-2. PubMed ID: 12344530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did he drown or was he murdered?
    Lau G
    Med Sci Law; 2002 Apr; 42(2):172-80. PubMed ID: 12033473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
    Middleton A; Morley KI; Bragin E; Firth HV; Hurles ME; Wright CF; Parker M;
    Eur J Hum Genet; 2016 Jan; 24(1):21-9. PubMed ID: 25920556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
    Babul R; Adam S; Kremer B; Dufrasne S; Wiggins S; Huggins M; Theilmann J; Bloch M; Hayden MR
    JAMA; 1993 Nov; 270(19):2321-5. PubMed ID: 8230594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease.
    Fiallos K; Applegate C; Mathews DJ; Bollinger J; Bergner AL; James CA
    Eur J Hum Genet; 2017 May; 25(5):530-537. PubMed ID: 28272539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participant choices for return of genomic results in the eMERGE Network.
    Hoell C; Wynn J; Rasmussen LV; Marsolo K; Aufox SA; Chung WK; Connolly JJ; Freimuth RR; Kochan D; Hakonarson H; Harr M; Holm IA; Kullo IJ; Lammers PE; Leppig KA; Leslie ND; Myers MF; Sharp RR; Smith ME; Prows CA
    Genet Med; 2020 Nov; 22(11):1821-1829. PubMed ID: 32669677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a preference-setting model for the return of individual genomic research results.
    Bacon PL; Harris ED; Ziniel SI; Savage SK; Weitzman ER; Green RC; Huntington NL; Holm IA
    J Empir Res Hum Res Ethics; 2015 Apr; 10(2):107-20. PubMed ID: 25742675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of target-date funds in 401(k) plans, 2007.
    Copeland C
    EBRI Issue Brief; 2009 Mar; (327):1-31. PubMed ID: 19388387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.
    Kaphingst KA; Ivanovich J; Elrick A; Dresser R; Matsen C; Goodman MS
    Mol Genet Genomic Med; 2016 Nov; 4(6):684-695. PubMed ID: 27896289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.